Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Heart MattersRethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Project Oncology®10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Project Oncology®Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Project Oncology®Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Project Oncology®Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Heart MattersSex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
- advertisement
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
CME/CEHER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CEWhy Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CEParallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
- advertisement
Advancing Care in Pretreated HR+/HER2- mBC
Medical Industry FeatureAdvancing Care in Pretreated HR+/HER2- mBC
Supportive Care in Patients with Pretreated HR+/HER2- mBC
Medical Industry FeatureSupportive Care in Patients with Pretreated HR+/HER2- mBC
The Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
Medical Industry FeatureThe Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Medical Industry FeatureNew 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Freeze-All Policy: Is It Right for Everyone?
Global Women's Health AcademyFreeze-All Policy: Is It Right for Everyone?
- 12/04/2025
- 12/03/2025
- 12/03/2025
- 12/03/2025
- 12/02/2025
- 12/01/2025